Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FQ64F
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,335
Award facts
- Contract value 100% obligated
- $2,335.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $2,335.13, was awarded on August 12, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56ML). The contract is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This delivery order carries no set-aside designation and is structured as a firm fixed-price contract with an ultimate completion date of August 13, 2025. The place of performance is located in Park Ridge, Illinois, where the vendor maintains its primary operations.
The DLA, operating under the Department of Defense, leverages its comprehensive IDC with DMS Pharmaceutical Group to procure pharmaceutical products and medical supplies supporting military health facilities nationwide. TYMLOS is an injectable medication used to treat osteoporosis, and this delivery order represents one of numerous pharmaceutical product deliveries the contractor fulfills for federal healthcare systems. DMS Pharmaceutical Group has consistently secured contracts with the DLA covering an extensive portfolio of prescription medications, biologics, and medical consumables, demonstrating its established role as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FQ64F?
SPE2DB25FQ64F was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FQ64F worth?
The government has obligated $2,335 on SPE2DB25FQ64F.
Is contract SPE2DB25FQ64F an order under another contract?
Yes. SPE2DB25FQ64F is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ64F competed?
The extent of competition for SPE2DB25FQ64F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award